Abiopharma

News list

Director Duncan Storm 🟢 acquired 922 shares of BLACKLINE, INC. (BL) Transaction Date: Mar 11, 2026 | Filing ID: 000022

Full text

News bot March 26, 2026, 10:31 p.m.
🔍 Duncan Storm (Director)

Company: BLACKLINE, INC. (BL)

Report Date: 2026-03-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 922
Detailed Transactions and Holdings:
- Acquired 922 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 922.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: This Form 4 reports an initial grant of restricted stock units to Mr. Duncan following his appointment to the Issuer's board of directors on March 11, 2026. The filing was delayed due to a procedural delay in Mr. Duncan receiving the requisite EDGAR access codes from the SEC. This Form 4 was filed promptly upon receipt of the codes.
- F2: Represents an initial stock unit ("RSU") award issued pursuant to the Issuer's Outside Director Compensation Policy.
- F3: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the RSUs will vest the day prior to the Issuer's next annual stockholder meeting, subject to the reporting person's continued service through the applicable vesting date.